Furthermore, we detected the expression of WDR43 and GNL2 in the lung samples of 15 PAH patients and 11 control subjects in GSE113439 and found significantly increased WDR43 and GNL2 expression (Fig. 11). The gene discussed is GNL2; the disease is pulmonary arterial hypertension.